These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents. Keri RS; Sasidhar BS; Nagaraja BM; Santos MA Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Recent advances of pyrazole-containing derivatives as anti-tubercular agents. Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767 [TBL] [Abstract][Full Text] [Related]
7. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents. Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological screening of pyrazole-conjugated benzothiazole analogs. Bhat M; Belagali SL Future Med Chem; 2018 Jan; 10(1):71-87. PubMed ID: 29235357 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the research of heterocyclic compounds as antitubercular agents. Yan M; Ma S ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656 [TBL] [Abstract][Full Text] [Related]
12. A review on various heterocyclic moieties and their antitubercular activity. Sharma S; Sharma PK; Kumar N; Dudhe R Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130 [TBL] [Abstract][Full Text] [Related]
13. Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents. Ramesh R; Shingare RD; Kumar V; Anand A; B S; Veeraraghavan S; Viswanadha S; Ummanni R; Gokhale R; Srinivasa Reddy D Eur J Med Chem; 2016 Oct; 122():723-730. PubMed ID: 27476117 [TBL] [Abstract][Full Text] [Related]
14. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis. Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928 [TBL] [Abstract][Full Text] [Related]
15. Developing pyrrole-derived antimycobacterial agents: a rational lead optimization approach. Biava M; Porretta GC; Poce G; Battilocchio C; Alfonso S; de Logu A; Manetti F; Botta M ChemMedChem; 2011 Apr; 6(4):593-9. PubMed ID: 21341373 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives. Pathak RB; Chovatia PT; Parekh HH Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129 [TBL] [Abstract][Full Text] [Related]